Homo sapiens Protein: CTSA | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-78427.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | CTSA | ||||||||||||||||||||||
Protein Name | cathepsin A | ||||||||||||||||||||||
Synonyms | GLB2; GSL; NGBE; PPCA; PPGB; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000191018 | ||||||||||||||||||||||
InnateDB Gene | IDBG-78417 (CTSA) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins. {ECO:0000269PubMed:1907282}. | ||||||||||||||||||||||
Subcellular Localization | Lysosome. | ||||||||||||||||||||||
Disease Associations | Galactosialidosis (GSL) [MIM:256540]: A lysosomal storage disease associated with a combined deficiency of beta- galactosidase and neuraminidase, secondary to a defect in cathepsin A. All patients have clinical manifestations typical of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes are recognized. The early infantile form is associated with fetal hydrops, edema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and a normal or mildly affected mental state. The juvenile/adult form is characterized by myoclonus, ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly, and long survival. {ECO:0000269PubMed:10944848, ECO:0000269PubMed:1756715, ECO:0000269PubMed:8514852, ECO:0000269PubMed:8968752}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 23 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR001563
Peptidase S10, serine carboxypeptidase IPR029058 Alpha/Beta hydrolase fold |
||||||||||||||||||||||
PFAM |
PF00450
|
||||||||||||||||||||||
PRINTS |
PR00724
|
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART | |||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P10619 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P10619 | ||||||||||||||||||||||
TrEMBL | U3KQ41 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 5476 | ||||||||||||||||||||||
UniGene | Hs.609336 | ||||||||||||||||||||||
RefSeq | NP_001121167 | ||||||||||||||||||||||
HUGO | HGNC:9251 | ||||||||||||||||||||||
OMIM | 613111 | ||||||||||||||||||||||
CCDS | CCDS46609 | ||||||||||||||||||||||
HPRD | 02020 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AK312898 AL008726 BC000597 BC093009 M22960 | ||||||||||||||||||||||
GenPept | AAA36476 AAH00597 AAH93009 BAG35745 CAA15501 CAI20248 | ||||||||||||||||||||||